For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

GlaxoSmithKline To Sell 5.69% Stake In Hindustan Unilever

By Staff
|

British multinational pharmaceutical company GlaxoSmithKline Plc will be selling 5.69 percent stake in Hindustan Unilever (HUL) via block deals at a price band of Rs 1,850-1,950 per share. The company said on Wednesday that this deal will be valued around $3.2-3.4 billion.

 
GlaxoSmithKline To Sell 5.69% Stake In Hindustan Unilever
Hindustan Unilever: Quotes, News
BSE 2323.20BSE Quote11.55 (-0.50%)
NSE 2321.40NSE Quote13.7 (-0.59%)

Morgan Stanley, HSBC and JPMorgan will be the advisors to the deal.

The price band of the deal is at a discount of 3-8 percent to the closing price of HUL of Rs 2,010.2 per share on Wednesday.

HUL's deal to buy GSK's Horlicks nutrition business for $3.8 billion for a consideration in cash and shares of HUL was completed in April 2020.

Story first published: Wednesday, May 6, 2020, 17:38 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X